Fund shareholders of Zylox-Tonbridge Medical Technology Co Ltd
ISIN CNE100004JD2 · China · LEI 254900QSIU3I0P3OEJ92
- Fund shareholders
- 20
- Of which ETFs
- 6 14 other funds
- Value held
- 32.1M $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Fidelity Emerging Asia Fund Fidelity Investment Trust | 5,132,278 | 15.1M $ | 0.78 % | as of Apr 30, 2026 ↗ |
| Fidelity Pacific Basin Fund Fidelity Investment Trust | 2,421,500 | 7.1M $ | 0.61 % | as of Apr 30, 2026 ↗ |
| Fidelity Advisor Emerging Asia Fund Fidelity Advisor Series VIII | 2,029,716 | 6M $ | 0.83 % | as of Apr 30, 2026 ↗ |
| THE EMERGING MARKETS SMALL CAP SERIES DFA INVESTMENT TRUST CO | 236,000 | 695.3K $ | 0.02 % | as of Apr 30, 2026 ↗ |
| Victory Emerging Markets Fund Victory Portfolios III | 174,500 | 485.7K $ | 0.07 % | as of Feb 28, 2026 ↗ |
| EMERGING MARKETS CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 165,500 | 487.6K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF SPDR INDEX SHARES FUNDS | 128,500 | 380.9K $ | 0.06 % | as of Mar 31, 2026 ↗ |
| First Trust Emerging Markets Small Cap AlphaDEX Fund First Trust Exchange-Traded AlphaDEX Fund II | 127,446 | 380.7K $ | 0.15 % | as of Mar 31, 2026 ↗ |
| College Retirement Equities Fund - Total Global Stock Account College Retirement Equities Fund | 122,000 | 364.5K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Victory Capital Growth Fund Victory Portfolios III | 93,000 | 274K $ | 0.03 % | as of Apr 30, 2026 ↗ |
| iShares MSCI China Small-Cap ETF iShares Trust | 81,000 | 225.4K $ | 0.23 % | as of Feb 28, 2026 ↗ |
| State Street Global All Cap Equity ex-U.S. Index Portfolio STATE STREET INSTITUTIONAL INVESTMENT TRUST | 37,000 | 110.5K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Emerging Markets Sustainability Core 1 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 29,500 | 86.9K $ | 0.01 % | as of Apr 30, 2026 ↗ |
| iShares MSCI Emerging Markets Small-Cap ETF iShares, Inc. | 29,000 | 80.7K $ | 0.02 % | as of Feb 28, 2026 ↗ |
| Emerging Markets Social Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 27,500 | 81K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| World ex U.S. Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 24,000 | 70.7K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Avantis Emerging Markets Equity ETF American Century ETF Trust | 21,000 | 58.4K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Avantis Emerging Markets Small Cap Equity ETF American Century ETF Trust | 16,500 | 45.9K $ | 0.04 % | as of Feb 28, 2026 ↗ |
| TCW White Oak Emerging Markets Equity Fund TCW FUNDS INC | 13,500 | 39.5K $ | 0.20 % | as of Apr 30, 2026 ↗ |
| iShares Neuroscience and Healthcare ETF iShares Trust | 9,000 | 26.4K $ | 0.51 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Fidelity Advisor Emerging Asia Fund Fidelity Advisor Series VIII | 0.83 % | as of Apr 30, 2026 ↗ |
| Fidelity Emerging Asia Fund Fidelity Investment Trust | 0.78 % | as of Apr 30, 2026 ↗ |
| Fidelity Pacific Basin Fund Fidelity Investment Trust | 0.61 % | as of Apr 30, 2026 ↗ |
| iShares Neuroscience and Healthcare ETF iShares Trust | 0.51 % | as of Apr 30, 2026 ↗ |
| iShares MSCI China Small-Cap ETF iShares Trust | 0.23 % | as of Feb 28, 2026 ↗ |
| TCW White Oak Emerging Markets Equity Fund TCW FUNDS INC | 0.20 % | as of Apr 30, 2026 ↗ |
| First Trust Emerging Markets Small Cap AlphaDEX Fund First Trust Exchange-Traded AlphaDEX Fund II | 0.15 % | as of Mar 31, 2026 ↗ |
| Victory Emerging Markets Fund Victory Portfolios III | 0.07 % | as of Feb 28, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF SPDR INDEX SHARES FUNDS | 0.06 % | as of Mar 31, 2026 ↗ |
| Avantis Emerging Markets Small Cap Equity ETF American Century ETF Trust | 0.04 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 20 | 0 | 10,918,440 | +1.2 % |
| 2026Q1 | 20 | +4 | 10,791,884 | -4.4 % |
| 2025Q4 | 16 | +2 | 11,285,494 | +18.0 % |
| 2025Q3 | 14 | +2 | 9,561,654 | -7.7 % |
| 2025Q2 | 12 | 0 | 10,358,569 | +47.7 % |
| 2025Q1 | 12 | 0 | 7,011,516 | -7.2 % |
| 2024Q4 | 12 | +1 | 7,556,169 | +7.2 % |
| 2024Q3 | 11 | +4 | 7,046,573 | +7.8 % |
| 2024Q2 | 7 | 0 | 6,538,073 | +32.3 % |
| 2024Q1 | 7 | +3 | 4,940,956 | +73.7 % |
| 2023Q4 | 4 | 2,845,000 |
Cite this page
Titelia. "Fund shareholders of Zylox-Tonbridge Medical Technology Co Ltd". https://titelia.com/en/stocks/zylox-tonbridge-medical-technology-co-ltd-CNE100004JD2